Upper Tract Urothelial Carcinoma

Disitamab Vedotin Plus Radiotherapy for Adjuvant Treatment of HER2-Expressing Cisplatin-Ineligible Upper Tract Urothelial Carcinoma

Photodynamic Diagnosis of Upper Tract Urothelial Carcinoma Using Fluorescence Endoscopy and Oral 5-ALA

A Home-Based Prehabilitation Exercise Intervention for Improving Physical Function in Patients With Bladder Cancer and Upper Tract Urothelial Cancer, Get Moving Trial

Circulating Tumor DNA (ctDNA) in High Grade Upper Tract Urothelial Cancer (UTUC)

Validation of a Circulating Tumor DNA Blood Test in Muscle-Invasive Bladder and Upper Tract Urothelial Cancer

OptiCross HD IVUS for Assessing Invasion Depth in Upper Tract Urothelial Carcinoma

Non-invasive Urinary Genomics-Based Risk Assessment for Early Urothelial Carcinoma Diagnosis

Radical Nephroureterectomy With vs Without Template Lymph Node Dissection in High-Risk Upper Tract Urothelial Carcinoma (T-LND UTUC)

Biomarker-Enriched Kidney-Preserving Strategy With Disitamab Vedotin Plus Tislelizumab in HER2-Positive High-Risk Upper Tract Urothelial Carcinoma

Flexible Ureterorenoscopy for Surveillance of Upper Tract Urothelial Carcinoma

Multimodal Kidney-Sparing Strategy for High-Risk Upper Tract Urothelial Carcinoma

Dual-Target Nectin-4/HER2 CAR-NK Cells in Advanced Urothelial Carcinoma

NECTAR Study: Neoadjuvant Toripalimab + 9MW2821 for Local UTUC

Cisplatin-Based Chemotherapy Followed by Maintenance Avelumab in UTUC

Ambulatory Flexible URS for UTUC Surveillance

Neoadjuvant Tislelizumab in Combination With Nab-Paclitaxel for UTUC

Treatment of Tumors in the Urinary Collecting System of the Kidney or Ureter Using a Light Activated Drug (WST11)

HEFTME System for Adjuvant Therapeutic Selection of Locally Advanced UTUC Postoperatively：A Perspective Cohort Study

A Study of RC48-ADC Combined with JS001 for Postoperative Adjuvant Treatment of Upper Tract Urothelial Carcinoma

Feasibility of Neo-adjuvant Versus Adjuvant Chemotherapy in Upper Tract Urothelial Carcinoma